Literature DB >> 18837788

Protective CD8 T cells against Plasmodium liver stages: immunobiology of an 'unnatural' immune response.

Michael Glen Overstreet1, Ian Andrew Cockburn, Yun-Chi Chen, Fidel Zavala.   

Abstract

SUMMARY: Immunization with high doses of irradiated sporozoites delivered by the bites of infected mosquitoes has been shown to induce protective responses against malaria, mediated in part by CD8(+) T cells. In contrast, natural transmission involving low exposure to live sporozoite antigen fails to elicit strong immunity. In this review, we examine how irradiated sporozoite immunization breaks the natural host-parasite interaction and induces protective CD8(+) T cells. Upon biting, the malaria-infected mosquitoes deposit parasites in the skin, many of which eventually exit to the bloodstream and infect hepatocytes. However, certain antigens, including the circumsporozoite (CS) protein, remain in the skin and are presented in the draining lymph node. These antigens prime specific CD8(+) T cells, which migrate to the liver where they eliminate parasitized hepatocytes. We discuss the relevance of the different tissue compartments involved in the induction and effector phases of this response, as well as the cellular requirements for priming and memory development of CD8(+) T cells, which include a complete dependence on dendritic cells and a near absolute need for CD4(+) T-cell help. Finally, we discuss the impact of the immunodominant CS protein on this protection and the implications of these findings for vaccine design.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18837788      PMCID: PMC2597001          DOI: 10.1111/j.1600-065X.2008.00671.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  136 in total

1.  CD8+ T cell-dependent elimination of dendritic cells in vivo limits the induction of antitumor immunity.

Authors:  I F Hermans; D S Ritchie; J Yang; J M Roberts; F Ronchese
Journal:  J Immunol       Date:  2000-03-15       Impact factor: 5.422

2.  IL-4 induces a wide-spectrum intracellular signaling cascade in CD8+ T cells.

Authors:  Ana Acacia de Sa Pinheiro; Alexandre Morrot; Sumana Chakravarty; Michael Overstreet; Jay H Bream; Pablo M Irusta; Fidel Zavala
Journal:  J Leukoc Biol       Date:  2007-01-02       Impact factor: 4.962

Review 3.  Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo.

Authors:  D Kägi; B Ledermann; K Bürki; R M Zinkernagel; H Hengartner
Journal:  Annu Rev Immunol       Date:  1996       Impact factor: 28.527

4.  Single immunizing dose of recombinant adenovirus efficiently induces CD8+ T cell-mediated protective immunity against malaria.

Authors:  E G Rodrigues; F Zavala; D Eichinger; J M Wilson; M Tsuji
Journal:  J Immunol       Date:  1997-02-01       Impact factor: 5.422

5.  CXCR3-dependent recruitment of antigen-specific T lymphocytes to the liver during murine cytomegalovirus infection.

Authors:  Kirsten L Hokeness; Elizabeth S Deweerd; Michael W Munks; Casey A Lewis; Ronald P Gladue; Thais P Salazar-Mather
Journal:  J Virol       Date:  2006-11-15       Impact factor: 5.103

6.  The circumsporozoite protein is an immunodominant protective antigen in irradiated sporozoites.

Authors:  Kota Arun Kumar; Gen-ichiro Sano; Silvia Boscardin; Ruth S Nussenzweig; Michel C Nussenzweig; Fidel Zavala; Victor Nussenzweig
Journal:  Nature       Date:  2006-12-06       Impact factor: 49.962

Review 7.  Pre-erythrocytic malaria vaccine: mechanisms of protective immunity and human vaccine trials.

Authors:  E Nardin; F Zavala; V Nussenzweig; R S Nussenzweig
Journal:  Parassitologia       Date:  1999-09

8.  CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection.

Authors:  M Matloubian; R J Concepcion; R Ahmed
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

9.  Influenza and vaccinia viruses expressing malaria CD8+ T and B cell epitopes. Comparison of their immunogenicity and capacity to induce protective immunity.

Authors:  M Rodrigues; S Li; K Murata; D Rodriguez; J R Rodriguez; I Bacik; J R Bennink; J W Yewdell; A Garcia-Sastre; R S Nussenzweig
Journal:  J Immunol       Date:  1994-11-15       Impact factor: 5.422

10.  Plasmodium sporozoites trickle out of the injection site.

Authors:  Lucy Megumi Yamauchi; Alida Coppi; Georges Snounou; Photini Sinnis
Journal:  Cell Microbiol       Date:  2007-01-09       Impact factor: 3.715

View more
  69 in total

1.  Killer lymphocytes use granulysin, perforin and granzymes to kill intracellular parasites.

Authors:  Farokh Dotiwala; Sachin Mulik; Rafael B Polidoro; James A Ansara; Barbara A Burleigh; Michael Walch; Ricardo T Gazzinelli; Judy Lieberman
Journal:  Nat Med       Date:  2016-01-11       Impact factor: 53.440

Review 2.  Approaches to malaria vaccine development using the retrospectroscope.

Authors:  Vanessa Sardá; David C Kaslow; Kim C Williamson
Journal:  Infect Immun       Date:  2009-05-18       Impact factor: 3.441

Review 3.  Malaria immunity in man and mosquito: insights into unsolved mysteries of a deadly infectious disease.

Authors:  Peter D Crompton; Jacqueline Moebius; Silvia Portugal; Michael Waisberg; Geoffrey Hart; Lindsey S Garver; Louis H Miller; Carolina Barillas-Mury; Susan K Pierce
Journal:  Annu Rev Immunol       Date:  2014       Impact factor: 28.527

4.  A potent malaria vaccine based on adenovirus with dual modifications at Hexon and pVII.

Authors:  Takayuki Shiratsuchi; Urvashi Rai; Izumi Kaneko; Min Zhang; Shiroh Iwanaga; Masao Yuda; Moriya Tsuji
Journal:  Vaccine       Date:  2017-10-28       Impact factor: 3.641

5.  COMPASS identifies T-cell subsets correlated with clinical outcomes.

Authors:  Lin Lin; Greg Finak; Kevin Ushey; Chetan Seshadri; Thomas R Hawn; Nicole Frahm; Thomas J Scriba; Hassan Mahomed; Willem Hanekom; Pierre-Alexandre Bart; Giuseppe Pantaleo; Georgia D Tomaras; Supachai Rerks-Ngarm; Jaranit Kaewkungwal; Sorachai Nitayaphan; Punnee Pitisuttithum; Nelson L Michael; Jerome H Kim; Merlin L Robb; Robert J O'Connell; Nicos Karasavvas; Peter Gilbert; Stephen C De Rosa; M Juliana McElrath; Raphael Gottardo
Journal:  Nat Biotechnol       Date:  2015-05-25       Impact factor: 54.908

6.  Quantitative and qualitative features of heterologous virus-vector-induced antigen-specific CD8+ T cells against Trypanosoma cruzi infection.

Authors:  Eiji Takayama; Takeshi Ono; Elena Carnero; Saori Umemoto; Yoko Yamaguchi; Atsuhiro Kanayama; Takemi Oguma; Yasuhiro Takashima; Takushi Tadakuma; Adolfo García-Sastre; Yasushi Miyahira
Journal:  Int J Parasitol       Date:  2010-07-08       Impact factor: 3.981

7.  Advances and challenges in malaria vaccine development.

Authors:  Ruobing Wang; Joseph D Smith; Stefan H I Kappe
Journal:  Expert Rev Mol Med       Date:  2009-12-16       Impact factor: 5.600

Review 8.  Genetically engineered, attenuated whole-cell vaccine approaches for malaria.

Authors:  Ashley M Vaughan; Ruobing Wang; Stefan H I Kappe
Journal:  Hum Vaccin       Date:  2010-01-29

9.  Why functional pre-erythrocytic and bloodstage malaria vaccines fail: a meta-analysis of fully protective immunizations and novel immunological model.

Authors:  D Lys Guilbride; Pawel Gawlinski; Patrick D L Guilbride
Journal:  PLoS One       Date:  2010-05-19       Impact factor: 3.240

Review 10.  Immunological mechanisms underlying protection mediated by RTS,S: a review of the available data.

Authors:  Vasee S Moorthy; W Ripley Ballou
Journal:  Malar J       Date:  2009-12-30       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.